Brief: Evoke Pharma Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
30/12/2021 21:11
Dec 30 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA INC - ON DECEMBER 29, CO RECEIVED NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
Source text: [https://bit.ly/3mJq8At]
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary